GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Auxilium Pharmaceuticals, Inc. (AUXL) [hlAlert]

Rating:
Buy AUXL
up 25.71 %

Auxilium Pharmaceuticals, Inc. (AUXL) rated Buy with price target $42 by Jefferies & Co

Posted on: Thursday,  Dec 17, 2009  8:25 AM ET by Jefferies & Co

Jefferies & Co rated Buy Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) on 12/17/2009. Previously Jefferies & Co rated Buy Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL)
on 01/15/2008., when the stock price was $29.01. Since then, Auxilium Pharmaceuticals, Inc. has gained 25.72% as of 01/29/2015's recent price of $36.47.
If you would have followed the previous Jefferies & Co's recommendation on AUXL, you would have gained 25.71% of your investment in 2571 days.

Auxilium Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and markets products for urology and sexual health. Auxilium markets Testim 1%, a topical testosterone gel, for the treatment of hypogonadism. Auxilium is developing additional Testim line extensions, as well as other products for urology and sexual health, including an enzyme in Phase II for the treatment of Peyronie's Disease that may also prove useful for the treatment of Dupuytren's Disease.

Our focus on growing and mid-sized companies enables us to identify unique investment ideas, which can make the difference in a tough market. Jefferies' research effort covers U.S. & International equity, high yield, convertibles, investment grade fixed income and post-reorganization securities, as well as special situations and quantitative research. The more than 120-person team of research professionals covers over 1,200 companies in more than 40 industries worldwide. Our analysts focus on identifying emerging industry themes and dig deeper to provide in-depth, thought provoking, objective research. Our analysts use a variety of quantitative and qualitative tools, integrating field analysis, proprietary channel checks and ongoing dialogue with the managements of the companies they cover. We utilize the latest technologies to deliver a research product that is timely, differentiated, and tailored to each customer's needs. Regular client access to companies and their management teams is provided through a wide variety of Jefferies hosted industry conferences, company management meetings and on-site tours.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/17/2009 8:25 AM Buy
None
30.61 42.00
as of 12/31/2009
1 Week down  -26.87 %
1 Month down  -36.16 %
3 Months down  -34.93 %
1 YTD down  -21.72 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/15/2008 8:25 AM Buy
None
29.01 40.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy